Priceline class action ceases—for the moment
Judge allows case to be dismissed after litigation funder withdraws… but if Labor is elected, proceedings could begin again A class action by disgruntled former Priceline franchisees, who alleged the …
No trademark for Priceline pink
Not enough of the colour used for it to be ‘distinguishing’, IP Australia rules Priceline has lost its bid to protect usage of what it claimed to be its “trademark” …
TGA to investigate ‘intentional’ paracetamol misuse
Report commissioned to look at self-harm risks from paracetamol The TGA has announced a report on the risks of self-harm from intentional paracetamol misuse. It commissioned the report, to be produced …
Weight-loss run on diabetes drug
‘Online’ GPs’ off-label prescribing of medication for weight loss key to shortage, says Twomey Diabetes patients are experiencing difficulties accessing supplies of type-2 diabetes treatment Ozempic because “entrepreneurial GPs” are …
Moderna vaccine sales treble in first quarter
COVID-19 mRNA vaccine sends income and profits through the roof Vaccine sales for US biotech company Moderna were three times what they were for the same period last year, according …
Wesfarmers gives tick to pharmacy model
API acquisition will form the cornerstone of a new $10 billion Wesfarmers health division, company reveals The acquisition of wholesalers Australian Pharmaceutical Industries by retail giant Wesfarmers has finally been …
Daigou downturn to continue
Multi-vit manufacturer doesn’t think China-focussed personal retail shopping volumes will increase soon, but CWH sales rise Swisse Vitamins decision locally to continue its shift towards prioritising supermarkets and online outlets …
More concern over co-pay costs
Australians face some of the world’s highest medicines co-payments in the world, says Better Access Australia Tonight’s Federal Budget is the ideal opportunity to introduce reform to help those on …
Third time lucky for AFT
NZ company wins appeal in Maxigesic comparative advertising case AFT Pharmaceuticals has been victorious in its marathon legal battle with Nuromol producer Reckitt Benckiser to declare in advertising that its …
Affordability key for revamped NMP: Guild
Submission to Medicines Policy review champions need for greater equity Medicines affordability should be an integral part of an updated National Medicines Policy, the Pharmacy Guild has said in its …
Meds suppliers monitor wharf strike
Long-running pay dispute flares up again, putting medicine supplies at potential risk Medicines industry groups are closely following re-ignited threats of strike action at wharves around Australia in case it …
Pharmacy owner hit with Ministerial legal bill
Federal Court affirms unsuccessful challenge to Health Minister’s discretionary powers must be paid by applicant A pharmacy owner who opposed the Health Minister’s discretionary power in allowing pharmaceutical benefits to …